US 11529347
SHP2 phosphatase inhibitors and methods of use thereof
granted A61KA61K31/4985A61K31/55
Quick answer
US patent 11529347 (SHP2 phosphatase inhibitors and methods of use thereof) held by Relay Therapeutics, Inc. expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4985, A61K31/55, A61K45/06, A61P